Systematic review of recent evidence for the safety and efficacy of elective endovascular repair in the management of infrarenal abdominal aortic aneurysm

Drury, D; Michaels, Jonathan; Jones, Laura; Ayiku, Lynda

doi:10.1002/bjs.5123

Cited by 187 publications

(123 citation statements)

References 71 publications

Supporting

Mentioning

111

Contrasting

Unclassified

Order By: Relevance

“…The results also confirm that careful long-term follow-up of surgical innovations is essential, as discussed in the Idea-Development-Exploration-Assessment-Long-term (IDEAL) study statement. 232 Comparing the rates we present in this report with others in the literature is difficult as many other studies present percentage risks [233][234][235][236] rather than rates. The study most contemporaneous with the EVAR trials is based on EUROSTAR registry data on 2846 patients undergoing EVAR between 1999 and 2004 and reported Kaplan-Meier estimates for reintervention at 1, 2, 3 and 4 years of 6%, 9%, 12% and 14%, respectively; 237 these are rather low compared with the rates of 12%, 14%, 17% and 21% that we present for EVAR trial 1.…”

Section: Graft-related Complications and Reinterventionsmentioning

confidence: 75%

The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy.

Brown

Powell²,

Thompson³

et al. 2012

Health Technol Assess

207

170

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service' . The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects...

show abstract

Section: Graft-related Complications and Reinterventionsmentioning

confidence: 75%

The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy.

Brown

Powell²,

Thompson³

et al. 2012

Health Technol Assess

207

170

View full text Add to dashboard Cite

show abstract

“…At 12 months, the endoleak rate was 21%, with increase in the number of type I endoleaks (6.8%) and type III endoleaks, and decrease in the number of type II endoleaks. The annual rate of secondary reintervention was 16.2% (20) . In the present casuistry, the percentages of secondary endoleaks were the following: type I, 2.9%; type II, 1.9%; type III, 2.9%; maintaining the high indices of endoleak types I and III as causes for reintervention during one-year follow-up.…”

Section: Discussionmentioning

confidence: 99%

Correção endovascular do aneurisma da aorta abdominal: análise dos resultados de único centro

et al. 2012

View full text Add to dashboard Cite

OBJETIVO: Avaliar os resultados clínicos imediatos e em médio prazo do tratamento endovascular em pacientes portadores de aneurisma da aorta abdominal em um centro de referência para doenças cardiovasculares. MATERIAIS E MÉTODOS: Estudo retrospectivo de uma série de pacientes submetidos a tratamento endovascular de aneurisma da aorta abdominal, no período de janeiro de 2009 a julho de 2010. Foram avaliados as características demográficas, o sucesso técnico, o sucesso terapêutico, a morbimortalidade, as complicações e a taxa de reintervenções perioperatórias imediatos, e após um ano de acompanhamento. RESULTADOS: Foram analisados 102 pacientes consecutivos com idade média de 72 ± 9 anos, sendo 79% deles do sexo masculino. Houve sucesso técnico em 97,1% e êxito terapêutico em 81% dos casos. A mortalidade perioperatória foi de 0,9% e a anual, de 7,8%. Foram necessárias reintervenções em 18,8% dos pacientes durante o seguimento. CONCLUSÃO: Em nosso estudo, os resultados obtidos justificam a realização desse procedimento nos pacientes com anatomia adequada.

show abstract

“…4 Conventional management of AAA is by open repair and is associated with a mortality rate of 1% to 6%. 5,6 Open abdominal surgery for treating AAA is connected with a high risk of kidney ischemia owing to aortic clamping, and requires ischemia-protecting procedures for the graft (eg, temporary axillofemoral bypass, aortoiliac shunt, aortofemoral shunt, aortofemoral bypass, femorofemoral bypass with extracorporal circulation, and cold perfusion of the graft.) 7.8 In 1991, when Parodi and associates 9 reported the first endovascular aneurysm repair (EVAR) by implanting stent grafts without aortic clamping, the procedure has become the preferable way in case of abdominal aneurysm treatment.…”

Section: Introductionmentioning

confidence: 99%

Untitled

Karczewski

Kulesza²,

Cichańska³

et al. 2016

Exp Clin Transplant

View full text Add to dashboard Cite

A 64-year-old man who had undergone a renal transplant 9 years earlier, was admitted to our hospital because of an asymptomatic, large, abdominal aortic aneurysm. During an introduction of a guide wire to the left common femoral artery dissection of iliac artery occurred with occlusion of graft renal artery. And endarterectomy of the common, external, and internal iliac arteries was performed, with no sufficient kidney inflow. A bypass was performed between the common iliac and the left common femoral artery with a kidney artery reanastomosis to the prosthesis. After 4 months of endovascular treatment of the aortic aneurysm, the patient's renal function remained unchanged.

show abstract

Systematic review of recent evidence for the safety and efficacy of elective endovascular repair in the management of infrarenal abdominal aortic aneurysm

Abstract: EVAR is technically effective and safe, with lower short-term morbidity and mortality rates than open surgery. However, there is a need for extended follow-up as the long-term success of EVAR in preventing aneurysm-related deaths is not yet known.

Cited by 187 publications

References 71 publications

The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy.

The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy.

Correção endovascular do aneurisma da aorta abdominal: análise dos resultados de único centro

Untitled

Contact Info

Product

Resources

About